Skip to main content
Signal8

Schuetz Thomas J.

SEC insider (Form 3/4/5 filer). CIK 0001591464. CHIEF EXECUTIVE OFFICER at Compass Therapeutics, Inc. (CMPX). 8 reported Form 4/5 transactions since Sep 2024; latest on Feb 8, 2026. Located in BOSTON, MA.

Companies Schuetz Thomas J. has filed insider reports for

  • Compass Therapeutics, Inc. (CMPX): Director, Officer, CHIEF EXECUTIVE OFFICER
Schuetz Thomas J. profile photo

Schuetz Thomas J.

CIK: 0001591464

Transaction Breakdown

Open Market Buys (P)1 (12.5%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)5 (62.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Compass Therapeutics, Inc. logo
CMPX

Compass Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

  • Compass Therapeutics, Inc. logo
    CMPX

    Compass Therapeutics, Inc.

    Feb 8, 2026
    Tax Payment
    Direct
    36.7K shares at avg. $6.52$239K
  • Compass Therapeutics, Inc. logo
    CMPX

    Compass Therapeutics, Inc.

    Jan 9, 2026
    Tax Payment
    Direct
    46.8K shares at avg. $5.35$250K
  • Compass Therapeutics, Inc. logo
    CMPX

    Compass Therapeutics, Inc.

    Jan 2, 2026
    Award
    Direct
    250K shares at avg. $5.17$1.3M
  • Compass Therapeutics, Inc. logo
    CMPX

    Compass Therapeutics, Inc.

    Nov 16, 2025
    Tax Payment
    Direct
    44K shares at avg. $4.83$213K
  • Compass Therapeutics, Inc. logo
    CMPX

    Compass Therapeutics, Inc.

    May 27, 2025
    Purchase
    Direct
    10K shares at avg. $2.11$21K
  • Compass Therapeutics, Inc. logo
    CMPX

    Compass Therapeutics, Inc.

    Feb 11, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    1.5M shares-
  • Compass Therapeutics, Inc. logo
    CMPX

    Compass Therapeutics, Inc.

    Feb 8, 2025
    Tax Payment
    Direct
    41.7K shares at avg. $3.50$146K
  • Compass Therapeutics, Inc. logo
    CMPX

    Compass Therapeutics, Inc.

    Jan 9, 2025
    Tax Payment
    Direct
    58.1K shares at avg. $1.86$108K

1-8 of 8